These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3968641)

  • 21. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptosomal dopamine from phenylalanine in brain: effects of some dopaminergic agents.
    Bagchi SP; Smith TM
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):447-58. PubMed ID: 523781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of rapid superfusion to differentiate the release of dopamine from striatal tissue induced by sympathomimetic amines from release induced by potassium.
    Caviness JN; Wightman RM
    J Pharmacol Exp Ther; 1982 Oct; 223(1):90-6. PubMed ID: 7120132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

  • 26. Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo.
    Garris PA; Wightman RM
    Synapse; 1995 Jul; 20(3):269-79. PubMed ID: 7570359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus.
    Patrick SL; Thompson TL; Walker JM; Patrick RL
    Brain Res; 1991 Jan; 538(2):343-6. PubMed ID: 2012977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphetamine-stimulated release of endogenous dopamine from the rat caudate nucleus in vivo.
    Philips SR; Robson AM
    Neurochem Res; 1983 Jun; 8(6):731-41. PubMed ID: 6621771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.
    Sabol KE; Seiden LS
    Brain Res; 1998 Sep; 806(1):69-78. PubMed ID: 9739110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices.
    Dyck LE; Boulton AA; Jones RS
    Eur J Pharmacol; 1980 Nov; 68(1):33-40. PubMed ID: 7449832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of stimulated dopamine release in the rat by in vivo voltammetry: the influence of stimulus duration on drug responses.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1986 Aug; 69(1):70-3. PubMed ID: 3748467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo voltammetric characterization of low affinity striatal dopamine uptake: drug inhibition profile and relation to dopaminergic innervation density.
    Stamford JA; Kruk ZL; Millar J
    Brain Res; 1986 May; 373(1-2):85-91. PubMed ID: 3487373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of haloperidol on amphetamine-induced increases in ascorbic acid and uric acid as determined by voltammetry in vivo.
    Mueller K; Haskett C
    Pharmacol Biochem Behav; 1987 Jun; 27(2):231-4. PubMed ID: 3628437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The amphetamine-like releasing effect of the alkaloid (-)cathinone on rat nucleus accumbens and rabbit caudate nucleus.
    Kalix P
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(1):43-9. PubMed ID: 7202229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
    Westerink BH; Spaan SJ
    J Neurochem; 1982 Mar; 38(3):680-6. PubMed ID: 7057187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct in vivo monitoring of dopamine released from two striatal compartments in the rat.
    Ewing AG; Bigelow JC; Wightman RM
    Science; 1983 Jul; 221(4606):169-71. PubMed ID: 6857277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry.
    Morgan ME; Vestal RE
    Life Sci; 1989; 45(21):2025-39. PubMed ID: 2601563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrochemistry in vivo: monitoring dopamine release in the brain of the conscious, freely moving rat.
    Lane RF; Blaha CD; Hari SP
    Brain Res Bull; 1987 Jul; 19(1):19-27. PubMed ID: 3651839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration.
    Ellison G; Eison MS; Huberman HS; Daniel F
    Science; 1978 Jul; 201(4352):276-8. PubMed ID: 26975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.